AUSTIN, Texas (AP) _ Aeglea Biotherapeutics Inc. (AGLE) on Thursday reported a loss of $5.5 million in its fourth quarter.
The Austin, Texas-based company said it had a loss of 41 cents per share.
The biopharmaceutical company posted revenue of $1.2 million in the period.
For the year, the company reported a loss of $21.7 million, or $2.22 per share. Revenue was reported as $4.6 million.
Aeglea shares have climbed 68 percent since the beginning of the year.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGLE at https://www.zacks.com/ap/AGLE
Keywords: Aeglea Biotherapeutics, Earnings Report